180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
| ATNF Stock | USD 1.72 0.10 5.49% |
Roughly 55% of 180 Life's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding 180 Life Sciences suggests that some traders are interested. The current market sentiment, together with 180 Life's historical and current headlines, can help investors time the market. In addition, many technical investors use 180 Life Sciences stock news signals to limit their universe of possible portfolio assets.
180 |
PALO ALTO, Calif., July 02, 2024 -- 180 Life Sciences Corp. , today announced that...
Read at globenewswire.com
 |
180 Life Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards 180 Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
180 Life Fundamental Analysis
We analyze 180 Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 180 Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 180 Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
180 Life is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
180 Life Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 180 Life stock to make a market-neutral strategy. Peer analysis of 180 Life could also be used in its relative valuation, which is a method of valuing 180 Life by comparing valuation metrics with similar companies.
Peers
180 Life Related Equities
| ZVSA | ZyVersa Therapeutics | 13.76 | ||||
| CDIO | Cardio Diagnostics | 10.34 | ||||
| ZURA | Zura Bio | 9.79 | ||||
| SONN | Sonnet Biotherapeutics | 9.37 | ||||
| CNSP | Cns Pharmaceuticals | 9.09 | ||||
| IMMX | Immix Biopharma | 6.82 | ||||
| PHIO | Phio Pharmaceuticals | 3.68 | ||||
| ENVB | Enveric Biosciences | 2.56 | ||||
| PALI | Palisade Bio | 2.15 |
Complementary Tools for 180 Stock analysis
When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |